Aims & Scopes
The Journal, launched in 2013, is designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, (basic, translational and clinical) research, clinicians/physicians, along with regulatory affairs, government authorities and representatives from payers, and policy makers.
The Journal’s content includes peer reviewed research, commentaries, news features, discussions, editorials and blogs on topics relevant to a broad international readership. The Journal also offers a knowledge center (called ADC University) offering the latest and most relevant information about Antibody-drug Conjugates (ADCs), BiSpecific Antibodies, Site Specific Antibody Drug Conjugates, Small Molecule Drug Conjugates (SMDC), and Engineered Antibody Fragments.
The purpose of the Journal is to present this information in an understandable and a useful format for all stakeholders.
Editorial Office | 4960 South Gilbert Rd, Suite 1-286, Chandler, AZ 85249 (USA)
Peter Hofland, PhD | Publisher and Executive Editor |
Martijn Pierik | Associate Publisher
Eric T. Rosenthal | Contributing Editor
Evan Wendt | Editor / Producer
Sonia Portillo | Associate Editor
Kseniya Wegbrait | Project Manager
Shaun Mehr | Media Advisor
German Wegbrait | Creative Design
Raul Gonzales | Programming/Web Development
Development and Creative Partners
InPress Media Group, LLC is a member of Crossref
ADC Review / Journal of Antibody-drug Conjugates is a peer reviewed journal with news, information and education sections. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a specific medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in this publication.
Copyright © 2015 InPress Media Group. All rights reserved. Republication or redistribution of InPress Media Group content, including by framing or similar means, is expressly prohibited without the prior written consent of InPress Media Group. InPress Media Group shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. ADC Review / Journal of Antibody-drug Conjugates is a registered trademarks and trademarks of InPress Media Group around the world. Add to Flipboard Magazine.
Topics to be Covered Introduction To Antibody Conjugates Overview Of Techniques In Quantitative Pharmacology No Such Thing As A Magic Bullet: The Hidden Challenges Of ADC Discovery And Development...